Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor.
B16 melanoma cells sterilized in vitro with 1,3-bis(2-chloroethyl)-1-nitrosourea or in vivo with trans-1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, have been used to enhance the percentage of tumor takes with small s.c. implants of viable cells and to reduce the latent period between tumor implantation and palpability. The admixture of trans-1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea-inactivated cells with viable cell implants reduced the number of cells required to produce tumors in 50% of the animals by approximately 3 log10 units and markedly reduced the time of tumor appearance from implants of up to 10(6) cells. Similar results were obtained with 1,3-bis(2-chloroethyl)-1-nitrosourea-sterilized cells. The growth-supporting effect obtained with the nitrosourea-inactivated cells appeared to be as pronounced as that previously reported, for this tumor system, with radiation-inactivated cells.
D000818:Animals; D002330:Carmustine / Q000494:pharmacology*; D002460:Cell Line; D002478:Cells, Cultured; D008545:Melanoma / Q000473:pathology*; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000209:etiology / Q000473:pathology; D009607:Nitrosourea Compounds / Q000494:pharmacology*; D011830:Radiation Effects; D012673:Semustine / Q000494:pharmacology*; D013997:Time Factors
D009607:Nitrosourea Compounds; D012673:Semustine; D002330:Carmustine